{"id":364464,"date":"2026-03-02T21:03:10","date_gmt":"2026-03-02T21:03:10","guid":{"rendered":"https:\/\/www.europesays.com\/ie\/364464\/"},"modified":"2026-03-02T21:03:10","modified_gmt":"2026-03-02T21:03:10","slug":"hss-reports-results-of-key-studies-on-targeted-medication-use-in-joint-replacement-surgery","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ie\/364464\/","title":{"rendered":"HSS Reports Results of Key Studies on Targeted Medication Use in Joint Replacement Surgery"},"content":{"rendered":"<p>Hospital for Special Surgery (HSS), the world\u2019s leading academic medical center focused on musculoskeletal health, today announced the results of several critical studies examining the use of targeted medications in joint replacement surgery to improve patient outcomes. These studies address key questions in perioperative medication management, an area that directly affects recovery, safety, and long\u2011term outcomes for joint replacement patients. The findings, presented at the annual meeting of the American Academy of Orthopaedic Surgeons (AAOS), evaluated outcomes following hip and knee replacement procedures.<\/p>\n<p>The first of the three studies, \u201cAspirin Versus Potent VTE Chemoprophylaxis (VTEC) in Total Knee Arthroplasty: Reduced Postoperative Pain and Complications with Aspirin Use,\u201d<strong> <\/strong>examined the experience of total knee arthroplasty (TKA) patients with postoperative pain who were also taking blood thinners. The study included 28,169 patients treated between 2016 and 2023; 18,413 received aspirin while 9,756 received a potent VTE.. Patients were monitored for 90 days following their procedure. The findings suggest that aspirin should be considered the preferred option for reducing postoperative pain in TKA patients.<\/p>\n<p>Patients on more-potent blood thinners tend to experience more pain, swelling and inflammation after surgery, said <a href=\"https:\/\/www.hss.edu\/profiles\/doctors\/brian-chalmers\" rel=\"nofollow noopener\" target=\"_blank\">Brian P. Chalmers, MD<\/a>, a hip and knee surgeon at HSS and one of the study\u2019s authors. \u201cWe have always known that non-steroidal anti-inflammatory medications can improve patients\u2019 swelling and inflammation after surgery. However, the traditional thought and belief has been that we should avoid those in patients on anticoagulation. Our data show there is less risk and less postoperative pain when these patients are utilizing aspirin.\u201d \u00a0\u00a0<\/p>\n<p>A second study, \u201cThe Effect of Concomitant Use of Potent Anticoagulation and Anti-Inflammatories on Early Outcomes of Total Hip Arthroplasty,\u201d retrospectively evaluated 5,881 total hip arthroplasty patients who were on anticoagulation. The surgeries were performed between 2016 and 2023; of those patients, 4,867 were concomitantly prescribed NSAIDs and 1,040 received anticoagulation alone. Researchers concluded that the concomitant use of NSAIDs in patients on anticoagulants did not increase the risk of wound-related bleeding complications.<\/p>\n<p>\u201cThe conventional thinking has often been that patients on an anticoagulant should not be on an NSAID, that there is going to be bleeding, more risk of wound problems and additional complications. But based on our retrospective data, we did not see increased risk in patients using both anticoagulation and NSAIDs. We did see some additional benefits, including less pain and a somewhat easier recovery,\u201d Dr. Chalmers stated. \u201cNSAIDs appear to be safe in this setting and may help decrease postoperative pain and reduce opioid use following surgery.\u201d<\/p>\n<p>The final study, \u201cCefazolin and the R-1 Side Chain: Why Your Joint Arthroplasty Patients With Cephalosporin Allergy Can Safely Be Given Cefazolin,\u201d assessed the safety and effectiveness of the antibiotic Cefazolin in patients with documented cephalosporin allergies. This is the first study to evaluate these questions.<\/p>\n<p>From 2016 to 2024, researchers compared patients with a reported cephalosporin allergy who received perioperative cefazolin with those who received alternative antibiotic prophylaxis. This study included 89,993 hip and knee arthroplasty patients. Of these, 1,267 had a documented allergy. The study resulted in zero incidence of IgE-mediated or \u201csevere\u201d type IV allergic reactions, concluding that cefazolin can be safely administered to most patients with an existing cephalosporin allergy.<\/p>\n<p>\u201cWhen patients have a mild allergic reaction, there is often a reflex to give them another antibiotic in a different family of drugs. However, alternative options aren\u2019t always as effective,\u201d said <a href=\"https:\/\/www.hss.edu\/profiles\/doctors\/matthew-austin\" rel=\"nofollow noopener\" target=\"_blank\">Matthew S. Austin, MD<\/a>, hip and knee surgeon at HSS and a study author. \u201cClear protocols should be put in place to guide decision-making when managing these types of allergies.\u201d<\/p>\n<p>These findings underscore HSS\u2019s ongoing commitment to challenging conventional assumptions and using data-driven research to refine perioperative care. The studies highlight how targeted medication strategies can improve safety, reduce complications and enhance outcomes for patients undergoing hip and knee arthroplasty.<\/p>\n<p><strong>Study Details\u00a0<\/strong><\/p>\n<p>\u201cAspirin Versus Potent VTE Chemoprophylaxis in Total Knee Arthroplasty: Reduced Postoperative Pain and Complications with Aspirin Use\u201d<\/p>\n<p>\u00a0Alex Anatone, Alexis Gabriel Gonzalez, Richard Hwang, David Andrew Kolin, Aaron Ira Weinblatt, Amar S Ranawat, Alejandro Gonzalez Della Valle, Brian Chalmers<\/p>\n<p>\u201cThe Effect of Concomitant Use of Potent Anticoagulation and Anti-Inflammatories on Early Outcomes of Total Hip Arthroplasty\u201d<\/p>\n<p>Alexis Gabriel Gonzalez, Aaron Ira Weinblatt, Agnes Cororaton Jones, Stephen Lyman, Richard Hwang, Alex Anatone, Carlo Marega, Alejandro Gonzalez Della Valle, Brian Chalmers<\/p>\n<p>\u201cCefazolin and the R-1 Side Chain: Why Your Joint Arthroplasty Patients With Cephalosporin Allergy Can Safely Be Given Cefazolin\u201d<\/p>\n<p>Josef Jolissaint, Katherine E Mallett, Andrew Thomson, Alberto V Carli, Matthew Austin<\/p>\n","protected":false},"excerpt":{"rendered":"Hospital for Special Surgery (HSS), the world\u2019s leading academic medical center focused on musculoskeletal health, today announced the&hellip;\n","protected":false},"author":2,"featured_media":364465,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[78],"tags":[169451,169450,17192,18,135,169453,119288,169455,19,17,66262,169452,72536,39041,169454],"class_list":["post-364464","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health","tag-arjr","tag-austinm","tag-chalmers","tag-eire","tag-health","tag-hip-arthroplasty","tag-hip-replacement","tag-hospital-for-special-surgery","tag-ie","tag-ireland","tag-knee","tag-knee-arthroplasty","tag-knee-replacement","tag-pressrelease","tag-research-clinical"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ie\/116161610224620499","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/364464","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/comments?post=364464"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/364464\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media\/364465"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media?parent=364464"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/categories?post=364464"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/tags?post=364464"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}